Vascular Magnetics Proves the Power of Philadelphia’s Entrepreneurial Ecosystem
PHILADELPHIA--(February 22, 2012) – When Vascular Magnetics raised $7 million in Series A financing this month, it demonstrated more than the potential of the start-up company’s proprietary, magnetically targeted drug delivery system for the treatment of peripheral artery disease (PAD). It also proved the power of Philadelphia’s entrepreneurial ecosystem. Vascular Magnetics was formed through a connection made at the University City Science Center’s QED Proof-of-Concept Funding Program